Related references
Note: Only part of the references are listed.Structural Biology and Evolution of the TGF-β Family
Andrew P. Hinck et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2016)
NMRFAM-SPARKY: enhanced software for biomolecular NMR spectroscopy
Woonghee Lee et al.
BIOINFORMATICS (2015)
Transforming growth factor-beta1 signaling blockade attenuates gastric cancer cell-induced peritoneal mesothelial cell fibrosis and alleviates peritoneal dissemination both in vitro and in vivo
Zhi-Feng Miao et al.
TUMOR BIOLOGY (2014)
Unchaining the beast; insights from structural and evolutionary studies on TGFβ secretion, sequestration, and activation
Ian B. Robertson et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2013)
Structural studies of the TGF-βs and their receptors - insights into evolution of the TGF-β superfamily
Andrew P. Hinck
FEBS LETTERS (2012)
Complexities of TGF-β Targeted Cancer Therapy
Erin C. Connolly et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2012)
iMOSFLM: a new graphical interface for diffraction-image processing with MOSFLM
T. Geoff G. Battye et al.
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2011)
Overview of the CCP4 suite and current developments
Martyn D. Winn et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2011)
Outgrowth of Drug-Resistant Carcinomas Expressing Markers of Tumor Aggression after Long-term TβRI/II Kinase Inhibition with LY2109761
Erin C. Connolly et al.
CANCER RESEARCH (2011)
Antibody Targeting of TGF-β in Cancer Patients
Scott Lonning et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2011)
TGF-β signalling is mediated by two autonomously functioning TβRI:TβRII pairs
Tao Huang et al.
EMBO JOURNAL (2011)
Exploring anti-TGF-ββ therapies in cancer and fibrosis
Lukas J. A. C. Hawinkels et al.
GROWTH FACTORS (2011)
Antagonistic VEGF variants engineered to simultaneously bind to and inhibit VEGFR2 and αvβ3 integrin
Niv Papo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
XDS
Wolfgang Kabsch
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2010)
Features and development of Coot
P. Emsley et al.
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2010)
PHENIX: a comprehensive Python-based system for macromolecular structure solution
Paul D. Adams et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2010)
Ternary Complex of Transforming Growth Factor-β1 Reveals Isoform-specific Ligand Recognition and Receptor Recruitment in the Superfamily
Sergei Radaev et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Targeting the Transforming Growth Factor-β pathway inhibits human basal-like breast cancer metastasis
Vidya Ganapathy et al.
MOLECULAR CANCER (2010)
Characterization of Reversible Associations by Sedimentation Velocity with UltraScan
Borries Demeler et al.
MACROMOLECULAR BIOSCIENCE (2010)
TβR-II Discriminates the High- and Low-Affinity TGF-β Isoforms via Two Hydrogen-Bonded Ion Pairs
Jason Baardsnes et al.
BIOCHEMISTRY (2009)
Transforming growth factor β signalling and matrix metalloproteinases in the mucosa overlying Crohn's disease strictures
A. Di Sabatino et al.
GUT (2009)
Modeling analytical ultracentrifugation experiments with an adaptive space-time finite element solution for multicomponent reacting systems
Weiming Cao et al.
BIOPHYSICAL JOURNAL (2008)
An anti-transforming growth factor β antibody suppresses metastasis via cooperative effects on multiple cell compartments
Jeong-Seok Nam et al.
CANCER RESEARCH (2008)
Cooperative assembly of TGF-β superfamily signaling complexes is mediated by two disparate mechanisms and distinct modes of receptor binding
Jay Groppe et al.
MOLECULAR CELL (2008)
Monte Carlo analysis of sedimentation experiments
Borries Demeler et al.
COLLOID AND POLYMER SCIENCE (2008)
Gene transfer of soluble transforming growth factor type II receptor by in vivo electroporation attenuates lung injury and fibrosis
Mizuho Yamada et al.
JOURNAL OF CLINICAL PATHOLOGY (2007)
Phaser crystallographic software
Airlie J. McCoy et al.
JOURNAL OF APPLIED CRYSTALLOGRAPHY (2007)
Aneurysm syndromes caused by mutations in the TGF-β receptor
Bart L. Loeys et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Inhibition of pulmonary and skeletal metastasis by a transforming growth factor-β type I receptor kinase inhibitor
Abhik Bandyopadhyay et al.
CANCER RESEARCH (2006)
Three key residues underlie the differential affinity of the TGFβ isoforms for the TGFβ type II receptor
G De Crescenzo et al.
JOURNAL OF MOLECULAR BIOLOGY (2006)
Assembly of TβRI:TβRII:TGFβ ternary complex in vitro with receptor extracellular domains is cooperative and isoform-dependent
JE Zúñiga et al.
JOURNAL OF MOLECULAR BIOLOGY (2005)
Development of TGF-β signalling inhibitors for cancer therapy
JM Yingling et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Selective inhibitors of type I receptor kinase block cellular transforming growth factor-β signaling
RR Ge et al.
BIOCHEMICAL PHARMACOLOGY (2004)
Overexpression of human transforming growth factor-β1 using a recombinant CHO cell expression system
ZC Zou et al.
PROTEIN EXPRESSION AND PURIFICATION (2004)
The 1.1 Å crystal structure of human TGF-β type II receptor ligand binding domain
CC Boesen et al.
STRUCTURE (2002)
Lifetime exposure to a soluble TGF-β antagonist protects mice against metastasis without adverse side effects
YA Yang et al.
JOURNAL OF CLINICAL INVESTIGATION (2002)
Blockade of TGF-β inhibits mammary tumor cell viability, migration, and metastases
RS Muraoka et al.
JOURNAL OF CLINICAL INVESTIGATION (2002)
Letter to the Editor:: Sequential resonance assignments of the extracellular ligand binding domain of the human TGF-β type II receptor
AP Hinck et al.
JOURNAL OF BIOMOLECULAR NMR (2000)
Share Paper
